<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01594528</url>
  </required_header>
  <id_info>
    <org_study_id>2012-A00048-35</org_study_id>
    <nct_id>NCT01594528</nct_id>
  </id_info>
  <brief_title>Behavior During Experimentally Induced Pain</brief_title>
  <official_title>Behavior During Experimentally Induced Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Esquirol</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Esquirol</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Numerous factors can influence the processing of pain message: the affective or emotional,
      the sensorial and the cognitive components. Interindividual variations at the emotional and
      cognitive levels may interfere with the pain message and the consecutive behavior. Some
      modifications in these components are observed in psychiatric troubles, but their influences
      on the behavior to pain have not been studied, although they have been studied in some
      populations characterized as non communicating, with obvious cognitive degradations (subject
      with dementia, older, newborns,â€¦).In an other study in course, the past pain experience is
      explored in relation to results to experimental pain tests, emotional and anxious
      characteristics. This present pilot study aims at studying the infra-verbal behavioural signs
      during experimentally induced pain in subjects with schizophrenia, major depression, and
      controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective is to search for behavioral non verbal indicators of pain during experimentally
      induced pain (pressure application, ischemia induction).

      Included subjects are subjected to experimental pain tests : pressure application (160 kPa)
      with an algometer to determine the pain with Visual Analogic Scale (VAS), and ischemia
      induction to determine the time needed to feel pain with an intensity equivalent to 3 with
      the VAS.

      Subjects are filmed during experimentation to identify the corporal mobility signs, facial
      expression signs and sonorous signs associated to pain stimulation.

      Neurophysiological measures complete these observations : surface electromyogram, heart rate
      measure, blood pressure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Indicators / Minute</measure>
    <time_frame>during pain tests (average 1 hour)</time_frame>
    <description>number of corporal mobility, facial expression and sound indicators</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Major Depression</condition>
  <arm_group>
    <arm_group_label>SC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>behavior as defined with facial, corporal and vocal indicators during experimental pain tests for subjects with schizophrenia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controls</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>behavior as defined with facial, corporal and vocal indicators during experimental pain tests for subjects without any psychiatric trouble</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>behavior as defined with facial, corporal and vocal indicators during experimental pain tests for subjects with major depression</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>pain tests</intervention_name>
    <description>pain induction with pressure application or ischemia on the arm</description>
    <arm_group_label>MD</arm_group_label>
    <arm_group_label>SC</arm_group_label>
    <arm_group_label>controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subjects with psychiatric trouble : diagnosis of schizophrenia or major depression
             according to the DSM-IV-TR criteria.

          -  control subjects : without known psychiatric history.

          -  age between 18 and 60.

        Exclusion Criteria:

          -  absence of consent, hospitalization under constraint, absence of health insurance.

          -  inability to answer the questionnaires

          -  pregnancy

          -  antalgic or analgesic treatment

          -  allergy to latex

          -  non stabilized high blood pressure, bad blood coagulation,

          -  peripheral neuropathy, nerve lesion, dermatosis at the superior extremities, muscular
             lesion or pathology at the upper member level

          -  non treated alcohol dependence

          -  illegal substance consumption in the past 48 hours

          -  participation to an other biomedical study during the 2 weeks before inclusion, and
             until the pain tests, if this study can interfere with the realization of the
             objectives
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique Malauzat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Esquirol</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Esquirol</name>
      <address>
        <city>Limoges</city>
        <zip>87025</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>March 13, 2012</study_first_submitted>
  <study_first_submitted_qc>May 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 9, 2012</study_first_posted>
  <results_first_submitted>January 31, 2017</results_first_submitted>
  <results_first_submitted_qc>December 17, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">March 22, 2019</results_first_posted>
  <last_update_submitted>December 17, 2018</last_update_submitted>
  <last_update_submitted_qc>December 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Esquirol</investigator_affiliation>
    <investigator_full_name>Dominique Malauzat</investigator_full_name>
    <investigator_title>MD, Head of Research Department</investigator_title>
  </responsible_party>
  <keyword>schizophrenia</keyword>
  <keyword>major depression</keyword>
  <keyword>pain</keyword>
  <keyword>behavior</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Control</title>
          <description>behavior during experimental pain tests for control subjects
pain tests: pain induction with pressure application or ischemia on the arm</description>
        </group>
        <group group_id="P2">
          <title>SChizophrenia</title>
          <description>behavior during experimental pain tests for subjects with schizophrenia
pain tests: pain induction with pressure application or ischemia on the arm</description>
        </group>
        <group group_id="P3">
          <title>Major Depression</title>
          <description>behavior during experimental pain tests for subjects with major depression pain tests: pain induction with pressure application or ischemia on the arm</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>subjects with major depression</population>
      <group_list>
        <group group_id="B1">
          <title>Major Depression</title>
          <description>subjects with major depression</description>
        </group>
        <group group_id="B2">
          <title>Schizophrenia</title>
          <description>subjects with schizophrenia</description>
        </group>
        <group group_id="B3">
          <title>Control</title>
          <description>subjects without psychiatric disorders</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="17"/>
            <count group_id="B3" value="16"/>
            <count group_id="B4" value="49"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46" lower_limit="37.5" upper_limit="51.5"/>
                    <measurement group_id="B2" value="42" lower_limit="35" upper_limit="49"/>
                    <measurement group_id="B3" value="40" lower_limit="33.5" upper_limit="48.5"/>
                    <measurement group_id="B4" value="41" lower_limit="35" upper_limit="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Indicators / Minute</title>
        <description>number of corporal mobility, facial expression and sound indicators</description>
        <time_frame>during pain tests (average 1 hour)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group of Subjects Presenting Schizophrenia SC</title>
            <description>subjects with diagnosis of schizophrenia according to the DSM-IV-TR and experimentating pain tests: pain induction with pressure application or ischemia on the arm.
and observation of the behavior as defined with facial, corporal and vocal indicators during experimental pain tests</description>
          </group>
          <group group_id="O2">
            <title>Group of Subjects Presenting Major Depression MD</title>
            <description>subjects presenting a diagnosis of major depression according to the DSM-IV-TR and experimentating pain tests: pain induction with pressure application or ischemia on the arm.
and observation of the behavior as defined with facial, corporal and vocal indicators during experimental pain tests</description>
          </group>
          <group group_id="O3">
            <title>Group of Subjects Without Psychiatric Troubles C</title>
            <description>control subjects without any psychiatric disorder and experimentating the same pain tests as the other groups: pain induction with pressure application or ischemia on the arm.
and observation of the behavior as defined with facial, corporal and vocal indicators during experimental pain tests</description>
          </group>
        </group_list>
        <measure>
          <title>Indicators / Minute</title>
          <description>number of corporal mobility, facial expression and sound indicators</description>
          <units>indicators/minute</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>vocal indicators</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.925" lower_limit="0" upper_limit="2.4"/>
                    <measurement group_id="O2" value="0.23" lower_limit="0" upper_limit="4.23"/>
                    <measurement group_id="O3" value="0.4" lower_limit="0" upper_limit="1.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>body indicators</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.45" lower_limit="0" upper_limit="1.6"/>
                    <measurement group_id="O2" value="0.59" lower_limit="0" upper_limit="2.1"/>
                    <measurement group_id="O3" value="0.55" lower_limit="0" upper_limit="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>facial indicators</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" lower_limit="0" upper_limit="1.5"/>
                    <measurement group_id="O2" value="0.4975" lower_limit="0.1" upper_limit="3.95"/>
                    <measurement group_id="O3" value="0.45" lower_limit="0.1" upper_limit="4.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.992</p_value>
            <p_value_desc>comparison between groups for body indicators</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.8</p_value>
            <p_value_desc>comparison between groups facial indicators</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.586</p_value>
            <p_value_desc>comparison between groups for vocal indicators</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 months</time_frame>
      <desc>no adverse event to be reported</desc>
      <group_list>
        <group group_id="E1">
          <title>Diagnosis</title>
          <description>diagnosis according to the DSM-IV-TR : major depression and schizophrenia, or control.
pain tests: pain induction with pressure application or ischemia on the arm</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Murielle Girard</name_or_title>
      <organization>Centre Hospitalier Esquirol</organization>
      <phone>0033555431028</phone>
      <email>murielle.girard@ch-esquirol-limoges.fr</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

